Menu Back to Event-Details

Enabling and Constraining Factors in Commercial ATMP Development: Learnings from the Escher-ATMP study

Track:
Content Hub Sessions

Day & Time:
April 18, 2:00PM - 2:30PM (Central Europe Standard Time)

Session Number:
CH03

Room Number:
Innovation Theatre

Level:
Intermediate

Type:
Session

Title:
Enabling and Constraining Factors in Commercial ATMP Development: Learnings from the Escher-ATMP study

Chair(s):
Renske M.T. Ten Ham, PharmD
Utrecht University, Netherlands

Description:
Advanced Therapy Medicinal Products(ATMP), gene, cell and tissue-based products, are highly innovative. Despite efforts, few have reached the market. Escher-Lygature study is the first to research challenges in their development.